Patents by Inventor Howard E. Greene

Howard E. Greene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
    Publication number: 20220362238
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Application
    Filed: January 13, 2022
    Publication date: November 17, 2022
    Inventors: Bronislava GEDULIN, Andrew A. YOUNG, Howard E. GREENE
  • Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
    Patent number: 11260053
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: March 1, 2022
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Bile acid recycling inhibitors for treatment of obesity and diabetes
    Patent number: 10555950
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes.
    Type: Grant
    Filed: April 12, 2016
    Date of Patent: February 11, 2020
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
    Publication number: 20190247390
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Application
    Filed: February 14, 2019
    Publication date: August 15, 2019
    Inventors: Bronislava GEDULIN, Andrew A. YOUNG, Howard E. GREENE
  • Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
    Patent number: 10251880
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 9, 2019
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
    Patent number: 10188646
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: January 29, 2019
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof
    Patent number: 10028952
    Abstract: Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: July 24, 2018
    Assignee: SATIOGEN PHARMACEUTICALS, INC
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • INFUSION DELIVERY DEVICES AND METHODS
    Publication number: 20170216404
    Abstract: Devices that include multi-reservoir infusion devices and systems for dispensing compositions for the treatment of subjects with an amylin agonist (e.g., the amylin agonist analog, pramlintide), wherein amylin agonists are administered in certain differential bolus and basal ratios to an administered insulin, as well as methods, compositions, and kits and articles of manufacture comprising said compositions for use in the treatment of responsive patients with an amylin and an insulin in ratios thereof that are distinct for bolus and basal administration.
    Type: Application
    Filed: April 14, 2017
    Publication date: August 3, 2017
    Inventor: Howard E. GREENE
  • Infusion delivery devices and methods
    Patent number: 9656017
    Abstract: Devices that include multi-reservoir infusion devices and systems for dispensing compositions for the treatment of subjects with an amylin agonist (e.g., the amylin agonist analog, pramlintide), wherein amylin agonists are administered in certain differential bolus and basal ratios to an administered insulin, as well as methods, compositions, and kits and articles of manufacture comprising said compositions for use in the treatment of responsive patients with an amylin and an insulin in ratios thereof that are distinct for bolus and basal administration.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: May 23, 2017
    Inventor: Howard E. Greene
  • METHODS OF TREATING DIABETES OR OBESITY USING BILE ACIDS, BILE SALTS, AND MIMICS THEREOF
    Publication number: 20160235745
    Abstract: Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 18, 2016
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES
    Publication number: 20160220577
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes.
    Type: Application
    Filed: April 12, 2016
    Publication date: August 4, 2016
    Inventors: Andrew A. YOUNG, Bronislava Gedulin, Howard E. Greene
  • Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof
    Patent number: 9345715
    Abstract: Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: May 24, 2016
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • Bile acid recycling inhibitors for treatment of obesity and diabetes
    Patent number: 9339480
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: May 17, 2016
    Assignee: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • INFUSION DELIVERY DEVICES AND METHODS
    Publication number: 20150366945
    Abstract: Devices that include multi-reservoir infusion devices and systems for dispensing compositions for the treatment of subjects with an amylin agonist (e.g., the amylin agonist analog, pramlintide), wherein amylin agonists are administered in certain differential bolus and basal ratios to an administered insulin, as well as methods, compositions, and kits and articles of manufacture comprising said compositions for use in the treatment of responsive patients with an amylin and an insulin in ratios thereof that are distinct for bolus and basal administration.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Inventor: Howard E. GREENE
  • BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
    Publication number: 20150087642
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Application
    Filed: November 26, 2014
    Publication date: March 26, 2015
    Inventors: Bronislava GEDULIN, Andrew A. YOUNG, Howard E. GREENE
  • BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
    Publication number: 20130059807
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Application
    Filed: February 22, 2012
    Publication date: March 7, 2013
    Applicant: Satiogen Pharmaceuticals, Inc.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent
    Patent number: 8318663
    Abstract: Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: November 27, 2012
    Assignee: Satiogen Pharmaceuticals, Inc.
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES
    Publication number: 20120157399
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes.
    Type: Application
    Filed: February 22, 2012
    Publication date: June 21, 2012
    Applicant: Satiogen Pharmaceuticals, Inc.
    Inventors: Andrew A. Young, Bronislava Gedulin, Howard E. Greene
  • BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
    Publication number: 20110294767
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.
    Type: Application
    Filed: May 26, 2011
    Publication date: December 1, 2011
    Applicant: Satiogen Pharmaceuticals, Inc.
    Inventors: Bronislava Gedulin, Andrew A. Young, Howard E. Greene
  • Treatment of Obesity or Diabetes with Bile Acid Sequestrants
    Publication number: 20110152204
    Abstract: Provided herein are methods of treating obesity and diabetes with labile bile acid sequestrants. An effective amount of a labile bile acid sequestrant may be orally administered to an obese or diabetic individual. A labile bile acid sequestrant provided herein may have a low affinity in the colon or rectum of a human for at least one bile acid or bile acid mimic that stimulates L-cells. A labile bile acid sequestrant may be a non-systemic labile bile acid sequestrant.
    Type: Application
    Filed: December 15, 2010
    Publication date: June 23, 2011
    Applicant: Satiogen Pharmaceuticals, Inc.
    Inventors: Bronislava GEDULIN, Howard E. Greene, JR.